随着Cenobamate的引入,Brivaracetam血清度的增加
Lena Bender1, Martin Hirsch1, Andreas Schulze-Bonhage1
1Epilepsy Center, University Medical Center, University of Freiburg, Freiburg, Germany.
在患者中,雪诺巴显著增加了27%的布里瓦拉塞坦血清水平. 这种相互作用可能是由于CYP2C19的抑制,需要仔细监测抗发作药物的疗效和不良反应.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 临床药房 临床药房
背景情况:
- 塞诺巴马特是一种用于焦点的新型抗发作药物.
- 它的肝脏代谢和酶作用需要相互作用研究.
- 关于赛诺巴与其他抗发作药物的相互作用的数据有限.
研究的目的:
- 为了研究赛诺巴酸盐对布里瓦拉塞坦血清水平的影响.
- 评估管理中的潜在药物相互作用.
主要方法:
- 在19名患者中的布里瓦拉塞坦血清度的回顾性分析.
- 在Cenobamate引入期间,布里瓦拉是稳定的基线药物.
- 匹配的费舍尔精确t测试被用于统计分析.
主要成果:
- 引入赛诺巴酸盐导致布里瓦拉塞坦血清水平显著增加,平均增加了27%.
- 与这种增加相关的不良影响是罕见的.
结论:
- 同时服用雪诺巴酸盐可显著提高布里瓦拉的血清度.
- 这种相互作用可能是由CYP2C19抑制的媒介.
- 在联合治疗期间,临床监测对于治疗疗效和不良事件评估至关重要.
更多相关视频
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Time Course of Drug Effect
Antiepileptic Drugs: Glutamate Antagonists
Sedatives and Hypnotics Drugs: Barbiturates
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
